Purdue Pharma Company Profile

✉ Email this page to a colleague

PURDUE PHARMA has eleven approved drugs.

There are forty-six US patents protecting PURDUE PHARMA drugs.

There are four hundred and fifty-seven patent family members on PURDUE PHARMA drugs in fifty-one countries and eight supplementary protection certificates in five countries.

International Patents:	457
US Patents:	46
Tradenames:	11
Ingredients:	11
NDAs:	11
Patent Litigation for Purdue Pharma:	See patent lawsuits for Purdue Pharma
PTAB Cases with Purdue Pharma as petitioner:	See PTAB cases with Purdue Pharma as petitioner
PTAB Cases with Purdue Pharma as patent owner:	See PTAB cases with Purdue Pharma as patent owner

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-001	Nov 20, 2014	AB	RX	Yes	Yes	9,775,809	⤷ Try a Trial	Y			⤷ Try a Trial
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-004	Nov 20, 2014	AB	RX	Yes	No	9,486,413	⤷ Try a Trial	Y			⤷ Try a Trial
Purdue Pharma	INTERMEZZO	zolpidem tartrate	TABLET;SUBLINGUAL	022328-002	Nov 23, 2011		DISCN	Yes	No	8,252,809	⤷ Try a Trial	Y			⤷ Try a Trial
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-002	Nov 20, 2014	AB	RX	Yes	No	9,486,412	⤷ Try a Trial	Y			⤷ Try a Trial
Purdue Pharma Lp	ADHANSIA XR	methylphenidate hydrochloride	CAPSULE, EXTENDED RELEASE;ORAL	212038-004	Feb 27, 2019		DISCN	Yes	No	10,507,186	⤷ Try a Trial	Y			⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-002	Nov 20, 2014	9,056,052	⤷ Try a Trial
Purdue Pharma Lp	BUTRANS	buprenorphine	FILM, EXTENDED RELEASE;TRANSDERMAL	021306-001	Jun 30, 2010	RE41571	⤷ Try a Trial
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-005	Nov 20, 2014	9,669,023	⤷ Try a Trial
Purdue Pharma Lp	HYSINGLA ER	hydrocodone bitartrate	TABLET, EXTENDED RELEASE;ORAL	206627-001	Nov 20, 2014	9,675,611	⤷ Try a Trial
Purdue Pharma	RYZOLT	tramadol hydrochloride	TABLET, EXTENDED RELEASE;ORAL	021745-001	Dec 30, 2008	6,607,748	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Extended-release Tablets	100 mg, 200 mg and 300 mg	➤ Subscribe	2009-06-18
➤ Subscribe	Transdermal System	5 mcg/hr, 10 mcg/hr, and 20 mcg/hr	➤ Subscribe	2013-06-06
➤ Subscribe	Extended-release Tablets	20 mg, 60 mg, and 120 mg	➤ Subscribe	2015-04-15
➤ Subscribe	Extended-release Tablets	15 mg	➤ Subscribe	2007-02-15
➤ Subscribe	Sublingual Tablets	1.75 mg and 3.5 mg	➤ Subscribe	2012-04-10
➤ Subscribe	Transdermal System	15 mcg/hr	➤ Subscribe	2013-12-16
➤ Subscribe	Extended-release Tablets	30 mg, 40 mg, 80 mg, and 100 mg	➤ Subscribe	2015-05-08
➤ Subscribe	Extended-release Tablets	30 mg and 60 mg	➤ Subscribe	2007-01-03

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0566709	SPC/GB04/012	United Kingdom	⤷ Try a Trial	PRODUCT NAME: TRAMADOL HYDROCHLORIDE, PARACETAMOL; REGISTERED: FR NL 25970 20020405; UK PL 00242/0384 20030925
1685839	92292	Luxembourg	⤷ Try a Trial	PRODUCT NAME: COMBINAISON D OXYCODONE EN TANT QUE COMPOSANT A ET DE NALOXONE EN TANT QUE COMPOSANT B SOUS TOUTES LES FORMES PROTEGES PAR LE BREVET DE BASE
2236132	CA 2015 00004	Denmark	⤷ Try a Trial	PRODUCT NAME: ZOLPIDEM OG FARMACEUTISK ACCEPTABLE SALTE HERAF, HERUNDER ZOLPIDEMTARTRAT; NAT. REG. NO/DATE: 47607 OG 47608 20120719; FIRST REG. NO/DATE: (B BE424286 OG BE424295 20120718
2236132	92636	Luxembourg	⤷ Try a Trial	PRODUCT NAME: ZOLPIDEM ET SES SELS PHARMACEUTIQUEMENT ACCEPTABLES
2236132	122015000006	Germany	⤷ Try a Trial	PRODUCT NAME: ZOLPIDEM UND PHARMAZEUTISCH VERTRAEGLICHE SALZE DAVON; NAT. REGISTRATION NO/DATE: 83439.00.00 83440.00.00 20120725 FIRST REGISTRATION: BELGIEN BE424286 BE424295 20120718
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.